98%
921
2 minutes
20
The Extravascular ICD (EV-ICD) is implanted outside of the patient's heart and vascular system. The defibrillation lead is tunneled in the substernal space, very close to the surface of the heart, thus allowing for additional pacing capabilities such as Post Shock Pacing, Anti-Tachycardia Pacing (ATP), and Pause Prevention Pacing. Early studies demonstrated the safety and efficacy profile of the EV-ICD, but patients with previous or existing cardiac devices or leads were excluded. In this case report we describe the implantation of an EV-ICD in a 68-year-old male patient, who had undergone a challenging extraction of a previous transvenous system due to infection and screened negative for a subcutaneous ICD (S-ICD). Given the lack of upper and lower venous accesses, it was also necessary to implant an epicardial bipolar lead connected to a single-chamber pacemaker as a backup during extraction, which also remained in place chronically. Follow-up was uneventful through the following 10 months, with stable system parameters and no infection relapse.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/pace.15170 | DOI Listing |
Eur Heart J Case Rep
August 2025
Department of Cardiovascular Medicine, University of Oxford, Wellington Square, Oxford OX1 2JD, UK.
Background: Implantable cardioverter-defibrillators (ICDs) prevent sudden cardiac death due to ventricular arrhythmia. A novel extravascular ICD (EV-ICD) system provides improved functionality over previous transvenous (TV-ICD) and subcutaneous (S-ICD) alternatives, particularly in younger patients. This includes limited bradycardia pacing, anti-tachycardia pacing therapy, and lower energy defibrillation, all within a smaller device profile compared to the S-ICD.
View Article and Find Full Text PDFJACC Clin Electrophysiol
July 2025
Cardiovascular Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address:
Eur Heart J Case Rep
July 2025
Department of Electrophysiology, AZ Sint-Jan Hospital, Ruddershove 10, Bruges B-8000, Belgium.
Background: Extra-vascular implantable cardioverter defibrillator (EV-ICD) is an emerging technique for ICD implantation with substernal lead placement. The system avoids the vasculature and can deliver anti-tachycardia and pause prevention pacing, with a generator size smaller than the existing subcutaneous device. While this device is now widely available, little is known about potential complications that may follow its implantation in real life context.
View Article and Find Full Text PDFHeartRhythm Case Rep
May 2025
Montreal Heart Institute, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
J Arrhythm
August 2025
Division of Cardiology, Department of Medicine Thomas Jefferson University Hospital Philadelphia Pennsylvania USA.
Background: Placement of cardiac implantable electronic devices (CIED) with leads that traverse the tricuspid valve is thought to contribute to tricuspid regurgitation (TR). However, there are relatively limited data comparing the impact of different CIED lead types on the incidence and progression of TR. This study sought to quantify the change in TR severity following implantation of CIEDs with different lead types.
View Article and Find Full Text PDF